Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost vs Brimonidine in POAG
NCT04205201Phase 2Completed
- Sponsor
- Chattogram Medical College
- Start
- Jun 2018
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of latanoprost in primary open-angle glaucoma (POAG), sponsored by Chattogram Medical College. Started Jun 2018; status: completed.
02
Drugs
latanoprost
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT04205201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04205201.